Eli Lilly said preliminary data from a late-stage study showed its weight-loss drug significantly reduced the risk of progression to type 2 diabetes among adults with prediabetes and obesity or overweight.
Related Posts
Elon Musk Says Tesla to Use Humanoid Robots Next Year
The CEO said the electric-vehicle maker would use the robots internally first before producing them for other companies.
BMW Hopes to Be a Steady Hand Amid EV Uncertainty
BMW is sticking to planned investments for its battery-powered future while holding onto its conventional gasoline-fueled roots, its technology chief Frank Weber said in an […]
BT Boosted by Carlos Slim Investment
- staff
- June 13, 2024
- 0
BT shares rose after it said Carlos Slim had bought a more-than 3% stake, making him the latest prominent investor to back the U.K. telecoms […]